Literature DB >> 24065328

Drug resistance in patients with leprosy in the United States.

Diana L Williams1, Cheryl Lewis, Felipe G Sandoval, Naoko Robbins, Stephen Keas, Thomas P Gillis, David M Scollard.   

Abstract

Molecular drug susceptibility testing was performed on 39 US patients with leprosy. Of these, 2 had dapsone-resistant Mycobacterium leprae and 1 of these patients also had rifampin-resistant M. leprae. Even though antileprosy drug resistance occurs in this leprosy population, resistance does not appear to be a major problem.

Entities:  

Keywords:  United States; drug resistance; leprosy

Mesh：

Substances：

Year:  2013        PMID： 24065328     DOI： 10.1093/cid/cit628

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  5 in total

1.  Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India.

Authors:  Niranjan Prakash Mahajan; Mallika Lavania; Itu Singh; Saraswati Nashi; Veeramani Preethish-Kumar; Seena Vengalil; Kiran Polavarapu; Chevula Pradeep-Chandra-Reddy; Muddasu Keerthipriya; Anita Mahadevan; Tagaduru Chickabasaviah Yasha; Bevinahalli Nanjegowda Nandeesh; Krishnamurthy Gnanakumar; Gareth J Parry; Utpal Sengupta; Atchayaram Nalini
Journal:  Am J Trop Med Hyg       Date:  2020-03       Impact factor: 2.345

2.  Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.

Authors:  E Cambau; P Saunderson; M Matsuoka; S T Cole; M Kai; P Suffys; P S Rosa; D Williams; U D Gupta; M Lavania; N Cardona-Castro; Y Miyamoto; D Hagge; A Srikantam; W Hongseng; A Indropo; V Vissa; R C Johnson; B Cauchoix; V K Pannikar; E A W D Cooreman; V R R Pemmaraju; L Gillini
Journal:  Clin Microbiol Infect       Date:  2018-03-01       Impact factor: 8.067

Review 3.  Treatment and Evaluation Advances in Leprosy Neuropathy.

Authors:  Gigi J Ebenezer; David M Scollard
Journal:  Neurotherapeutics       Date:  2021-11-19       Impact factor: 7.620

4.  qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.

Authors:  Sergio Araujo; Luiz Ricardo Goulart; Richard W Truman; Isabela Maria B Goulart; Varalakshmi Vissa; Wei Li; Masanori Matsuoka; Philip Suffys; Amanda B Fontes; Patricia S Rosa; David M Scollard; Diana L Williams
Journal:  PLoS Negl Trop Dis       Date:  2017-06-01

5.  Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.

Authors:  Diana L Williams; Sergio Araujo; Barbara M Stryjewska; David Scollard
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.